文献速递妇科生殖医学

Adropin在多囊卵巢综合征代谢与激素异常中的潜在作用

Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome.
PubMed 文献 · Reprod Biomed Online · 2021-02-02

该研究纳入220例PCOS患者和67例对照,检测血浆及卵泡液中Adropin浓度,发现PCOS患者血浆和卵泡液Adropin均降低,且与BMI、游离雄激素指数、HOMA-IR等负相关,与SHBG和HDL正相关;Adropin与PCOS的关联可能由SHBG介导。

要点

  • PCOS患者血浆和卵泡液Adropin浓度均低于对照。
  • Adropin与SHBG、HDL正相关,与BMI、HOMA-IR等负相关。
  • SHBG可能介导Adropin与PCOS高雄激素血症的关联。

核心结论

  • PCOS患者血浆和卵泡液Adropin浓度降低,可能影响胰岛素抵抗的发生发展。
  • Adropin与PCOS高雄激素血症的关联可能通过SHBG介导。
  • Adropin降低与PCOS中支链氨基酸代谢异常相关。

研究设计与样本

  • 纳入220例PCOS患者和67例对照,采集基础状态血浆检测Adropin。
  • 另收集50例PCOS患者和30例对照的卵泡液进行Adropin分析。

主要发现

  • PCOS患者血浆和卵泡液Adropin浓度低于对照(P < 0.001;P = 0.017)。
  • Adropin与BMI、游离雄激素指数、HOMA-IR、雄烯二酮和甘油三酯负相关,与SHBG和HDL正相关(均P < 0.05)。
  • 肥胖或糖耐量异常的PCOS患者Adropin浓度更低(P < 0.001)。
  • PCOS组卵泡液Adropin与HOMA-IR、异亮氨酸和缬氨酸负相关(均P < 0.05)。
  • 校正年龄、BMI、HOMA-IR和HDL后,SHBG仍显著影响血浆Adropin浓度(P = 0.022);校正年龄和BMI后,Adropin降低者患PCOS的比值比仍显著(P = 0.045);校正SHBG后Adropin与PCOS的关联消失。

临床怎么用

  • Adropin可作为评估PCOS代谢异常(尤其胰岛素抵抗)的潜在生物标志物。
  • 临床关注PCOS患者SHBG水平,其可能介导Adropin与高雄激素的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The study aimed to explore the effects of adropin on hormone concentrations and glucolipid and amino acid metabolism in patients with polycystic ovary syndrome (PCOS). DESIGN: A total of 220 PCOS patients and 67 controls were recruited and basal state plasma was collected for adropin measurement. Follicular fluids from 50 PCOS patients and 30 controls were also collected for adropin analysis. RESULTS: Plasma and follicular fluid adropin concentrations were lower in PCOS patients than controls (P < 0.001; P = 0.017). Adropin concentrations were negatively correlated with body mass index (BMI), free androgen index, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), androstenedione and triglycerides, and positively correlated with sex hormone-binding globulin (SHBG) and high-density lipoprotein (HDL) (all P < 0.05). PCOS patients who were either obese or glucose intolerant had lower adropin concentrations (P < 0.001). Follicular fluid adropin concentrations were negatively correlated with HOMA-IR, isoleucine and valine in the PCOS group (all P < 0.05). After adjusting for age, BMI, HOMA-IR and HDL, SHBG still significantly impacted the concentration of plasma adropin (P = 0.022). After adjusting for age and BMI, the odds of subjects with reduced adropin concentrations having PCOS still remained significant (P = 0.045). The association between plasma adropin and PCOS disappeared following SHBG adjustment. CONCLUSIONS: The concentrations of adropin in plasma and follicular fluid were lower in PCOS patients, which might affect the development of insulin resistance. The association between adropin concentrations and hyperandrogenaemia in PCOS might be mediated through SHBG. The decreased adropin concentrations are associated with abnormal branched-chain amino acid metabolism in PCOS.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Ye Z, Zhang C, Zhao Y, et al. Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome. Reprod Biomed Online. 2021. PMID: 33612434. doi:10.1016/j.rbmo.2021.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。